Week Ending March 8, 2021

Organization Urges That Patients With Lung Cancer Worldwide Have Access to COVID-19 Vaccine
“The International Association for the Study of Lung Cancer (IASLC) recently joined more than 100 cancer centers and organizations in requesting that leading public health officials, President Joseph Biden and other members of the administration prioritize the delivery of a COVID-19 vaccine to cancer survivors and patients receiving active treatment.”

New Technology Significantly Improves Lung Cancer Surgery
“Researchers at UPMC and the University of Pittsburgh School of Medicine are using groundbreaking tumor-highlighting technology to better visualize lung cancer tissue—giving surgeons a significantly better chance of finding and removing more cancer cells than previously possible.”

Merck withdraws Keytruda from SCLC indication amid FDA crackdown
“On 1 March, Merck announced the voluntary withdrawal of its Keytruda (pembrolizumab) immunotherapy for the treatment of patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy.”

Targeted Radiation Hits The Mark For Lung Cancer Patient
“Eighty-two year old Larry Sams sits next to his wife Carol in a conference room where sun streams in at the OSF Moeller Cancer Center in Alton, Illinois and declares he feels special and lucky.”

Langer Discusses Trials in Multiple Settings for Non–Small Cell Lung Cancer
“Corey J. Langer, MD, director, Thoracic Oncology, Abramson Cancer Center and professor of Medicine, Hospital of the University of Pennsylvania in Philadelphia, PA, discusses treatment options for a patient with non–small cell lung cancer (NSCLC) based on the clinical trial research.”

Entrectinib Impresses in Certain Lung Cancers
“A majority of patients with advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC) obtained durable remissions with the ROS1 inhibitor entrectinib (Rozlytrek), according to an updated integrated analysis of three clinical trials.”

Palliative Care Considered Beneficial, Though Infrequently Used in Lung Cancer
“Nearly two-thirds of patients with epidermal growth factor receptor (EGFR) mutation-positive lung cancer do not use palliative care, despite many having a favorable opinion of it, according to the results of a patient-centered survey study presented at the 2020 World Conference on Lung Cancer in Singapore.”

A new effect of red ginseng: suppression of lung cancer metastasis
“Development of KIST-maximized ginsenoside (KMxG) using a microwave processing method for ginseng that increase the trace amounts of Rk1 and Rg5. Ginsenosides Rk1 and Rg5 effectively inhibit the metastasis of lung cancer”